Cook predicts blockbuster with new stent
Bloomington-based Cook Medical has won European approval for a new artery-opening device for the legs that it predicts will
be a blockbuster.
Bloomington-based Cook Medical has won European approval for a new artery-opening device for the legs that it predicts will
be a blockbuster.
Industry groups in the life sciences, medical and information technology realms have helped lure companies to the region
and foster upstarts. Funding is almost always an issue, but it’s not the only barrier. Getting medical
devices to market often requires product design, development and marketing resources that aren’t
always apparent to upstarts.
Biomet Inc. yesterday reported a $170.9 million loss in its fiscal fourth quarter as the result of more than $300 million
in special charges.
Purdue University researcher Philip Low, also the chief science officer for West Lafayette-based Endocyte Inc., has developed
a prostate cancer “homing device” to help anti-cancer agents specifically target prostate
cancer tumors.
Taking science from the laboratory to the commercial market takes too much time and is littered with potential pitfalls along the way.
In a state steeped in advanced research that spawns biomedical companies by the dozen, Apricity LLC is preposterously low-tech,
given that its latest product is nothing more than a warm blanket.
Catheter Research Inc. now is flying high—even in the midst of a bad economy.
Indianapolis-based medical-device startup NICO Corp. has raised $1.73 million from investors.
Economists call it a “virtuous cycle” when successful entrepreneurs plow their gains into new businesses. Jim Pearson calls
it another day on the job. The former Suros Surgical Systems Inc. CEO is attempting to repeat what he already has done: Build
a company to bring a promising medical device all the way from the drawing board to the market.
Advantis Medical Inc. manufactures custom trays and cases for orthopedic surgical devices. That core product line brought Advantis some $5.2 million in revenue in 2004, double the amount of the previous year, said Advantis President Jim Spencer.